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Abstract
Introduction: The objective was to evaluate the association between fetal sex and 
adverse pregnancy outcome, while correcting for fetal growth and gestational age 
at delivery.
Material and methods: Data from the Netherlands Perinatal Registry (1999‐2010) 
were used. The study population comprised all white European women with a sin‐
gleton delivery between 25+0 and 42+6 weeks of gestation. Fetuses with structural 
or chromosomal abnormalities were excluded. Outcomes were antepartum death, 
intrapartum/neonatal death (from onset of labor until 28 days after birth), perinatal 
death (antepartum death or intrapartum/neonatal death), a composite of neonatal 
morbidity (including infant respiratory distress syndrome, sepsis, necrotizing enter‐
ocolitis, meconium aspiration, persistent pulmonary hypertension of the newborn, 
periventricular leukomalacia, Apgar score <7 at 5 minutes, and intracranial hemor‐
rhage) and a composite adverse neonatal outcome (perinatal death or neonatal mor‐
bidity). Outcomes were expressed stratified by birthweight percentile (<p10 [small 
for gestation], p10‐90 [normal weight], >p90 [large for gestation]) and gestational 
age at delivery (25+0‐27+6, 28+0‐31+6, 32+0‐36+6, 37+0‐42+6 weeks). The association 
between fetal sex and outcome was assessed using the fetus at risk approach.
Results: We studied 1 742 831 pregnant women. We found no increased risk of an‐
tepartum, intrapartum/neonatal and perinatal death in normal weight and large‐for‐
gestation males born after 28+0 weeks compared with females. We found an increased 
risk of antepartum death among small‐for‐gestation males born after 28+0 weeks (rel‐
ative risk [RR] 1.16‐1.40). All males born after 32+0 weeks of gestation suffered more 
neonatal morbidity than females regardless of birthweight percentile (RR 1.07‐1.34). 
Infant respiratory distress syndrome, sepsis, persistent pulmonary hypertension of 
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1  | INTRODUC TION
In pregnancy, fetal sex is known to affect placentation,1 intrauterine 
growth,2 preterm birth3‐9 and perinatal outcome.10‐13 Previous stud‐
ies have suggested a male predominance in miscarriage,10 antepar‐
tum death,11‐13 perinatal death, fetal distress, respiratory distress 
syndrome and low Apgar scores.14 Although these studies provide 
valuable information about gender differences, outcomes should be 
interpreted with care because of methodological weaknesses. First, in 
some studies, outcomes were adjusted for absolute birthweight and 
gestational age at delivery while not taking into account that healthy 
males are on average heavier than healthy females at any given gesta‐
tional age.2 This may lead to comparison of small‐for‐gestation (SGA) 
males with normal weight females and falsely suggest a higher risk 
of adverse outcome among males. In other studies, outcomes were 
based on calculated male to female ratio for adverse outcome, ex‐
pressed as the number of adverse outcomes among males divided 
by the number of adverse outcomes among females. Since, histori‐
cally, more males are born, this comparison may also falsely suggest 
a higher risk of adverse outcome among males. Secondly, previous 
studies did not investigate whether there was an association between 
gestational age at delivery, fetal growth and perinatal outcome.
These methodological limitations can be overcome when birth‐
weight percentiles are used to express growth instead of absolute 
birthweight, stratification for SGA, normal weight and large‐for‐ges‐
tational‐age (LGA) males, females and gestational age at delivery is 
performed, and the fetus at risk approach is used to rule out bias 
through unequal numbers of male and female infants.
The objective of this hypothesis‐generating study was to eval‐
uate the association between fetal sex and adverse pregnancy out‐
come, including antepartum death, intrapartum/neonatal death and 
neonatal morbidity, whilst correcting for fetal growth and gesta‐
tional age at delivery.
2  | MATERIAL AND METHODS
This study was performed in a nationwide cohort with the use of the 
Netherlands Perinatal Registry (PERINED). The PERINED consists of 
population‐based data that contain information on pregnancies, deliv‐
eries and re‐admissions until 28 days after birth. The PERINED data‐
base is obtained by a validated linkage of three different registries: the 
midwifery registry, the obstetrics registry and the neonatology regis‐
try of hospital admissions.15,16 Records are entered in the PERINED 
registry at the child's level. The coverage of the PERINED registry is 
approximately 96% of all deliveries in the Netherlands. It contains 
pregnancies of ≥22 weeks' gestational age and is used primarily for 
annual assessment of the quality indicators of obstetric care.
We included all white European women who delivered a sin‐
gleton baby between 25+0 and 42+6 weeks of gestation in The 
Netherlands between 1 January 1999, and 31 December 2010. 
We excluded all women who delivered an infant with congenital 
anomalies.17 Women of other ethnicities were excluded to avoid 
bias through differences in optimal weight for gestation in other 
groups not taken into account in the Dutch birthweight refer‐
ence curves and to avoid bias through the presence of different 
risk profiles for adverse pregnancy outcomes among non‐white 
European women.
Gestational age at delivery was defined as extremely preterm 
(25+0‐27+6 weeks), very preterm (28+0‐31+6 weeks), moderate to late 
preterm (32+0‐36+6 weeks) and term (37+0‐42+6 weeks). The Dutch 
reference curves for birthweight by gestational age stratified for 
parity and sex were used.18 SGA was defined as a birthweight below 
the 10th percentile for gestation (<p10), appropriately grown for ges‐
tation (normal weight) as a birthweight between the 10th and 90th 
percentile (p10‐90) for gestation, and LGA as birthweight above the 
90th percentile (>p90) for gestation.
the newborn, Apgar score <7 at 5 minutes, and intracranial hemorrhage all occurred 
more often in males than in females.
Conclusions: Small‐for‐gestation males have an increased risk of antepartum death 
and all males born after 32+0 weeks of gestation have an increased risk of neona‐
tal morbidity compared with females. In contrast to findings in previous studies we 
found no increased risk of antepartum, intrapartum/neonatal or perinatal death in 
normal weight and large‐for‐gestation males born after 28+0 weeks.
K E Y W O R D S
adverse outcome, antepartum death, intrapartum death, neonatal death, sex, small for 
gestational age
Key message
Small‐for‐gestational‐age males have increased risks of 
antepartum death; all males born after 32+0 weeks have 
increased risks of neonatal morbidity compared with fe‐
males. We found no increased risk of any mortality in 
normal weight or large‐for‐gestational‐age males after 
28+0 weeks.
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Our outcome measures were antepartum death, intrapartum/
neonatal death, perinatal death, a composite of neonatal morbidity, 
and a composite of adverse perinatal outcome. Antepartum death 
was defined as stillbirth that occurred between 25+0 weeks gesta‐
tional age and the onset of labor. Intrapartum and neonatal death 
were defined as death between the onset of labor and 28 days after 
birth. Perinatal death was defined as antepartum death, intrapartum 
death and neonatal death with definitions as described. The com‐
posite measure of neonatal morbidity consisted of: infant respiratory 
distress syndrome (IRDS), neonatal sepsis, necrotizing enterocolitis 
(NEC), meconium aspiration, persistent pulmonary hypertension of 
the newborn (PPHN), periventricular leukomalacia, Apgar score <7 
at 5 minutes and intracranial hemorrhage (ICH), all as judged by the 
clinician within the first admission after birth. If a neonate suffered 
from neonatal morbidity and died within 28 days after birth, it was 
considered to have suffered intrapartum/neonatal death and not 
morbidity. The composite measure of adverse perinatal outcome 
consisted of the composite measure of neonatal morbidity and peri‐
natal death.
PERINED registered demographic and obstetric characteristics 
including maternal age, parity, hypertensive complications of preg‐
nancy (chronic hypertension, pregnancy‐induced hypertension, 
preeclampsia)19 and socioeconomic status. Parity was categorized 
into nulliparous and multiparous women. The socioeconomic status 
score is based on mean income level, the percentage of households 
with a low income, the percentage of inhabitants without a paid job 
and the percentage of households with on average a low education 
in a postal code area.20 The continuous socioeconomic status score 
was categorized into a low, middle and high group, based on percen‐
tile ranges (<25th percentile, 25‐75th percentile, >75th percentile).
Demographic and obstetric baseline characteristics were com‐
pared between males and females using Student's t test and Chi‐
square test as appropriate. We tested for interaction between fetal 
sex and gestational age at delivery and between fetal sex and birth‐
weight percentile. These tests were performed separately for all 
outcome measures. If interaction was found to be present (defined 
as a P < 0.001), analyses were performed, stratified for gestational 
age at delivery (25+0‐27+6 weeks, 28+0‐31+6 weeks, 32+0‐36+6 weeks, 
37+0‐42+6 weeks) and birthweight percentile group (SGA, normal 
weight and LGA).
The fetus at risk approach was used to determine the association 
between fetal sex and pregnancy outcome, expressed as relative risk 
(RR) with 95% confidence intervals (CI) within the strata for birth‐
weight percentile and gestational age at delivery.
2.1 | Antepartum death
For a fetus to be at risk of antepartum death (AD) at 36+0 weeks it 
is necessary to be alive at 36+0 weeks. Consequently, the risk of an‐
tepartum death was calculated as a proportion of the ongoing preg‐
nancies (OP) at a particular gestation.
Risk of antepartum death at week n = ADn/OPn*100.
2.2 | Intrapartum/neonatal death
In concurrence, the risk of intrapartum/neonatal death (IND) at any 
gestational age is obtained by dividing the number of intrapartum 
and neonatal deaths at that gestation by the number of neonates at 
risk of intrapartum/neonatal death at that gestation. The neonates 
at risk of intrapartum/neonatal death at a certain gestational age in‐
clude all delivered neonates (DN) that did not die antepartum, mean‐
ing all pregnancies with onset of labor.
Risk of intrapartum/neonatal death at week n = INDn/DNn*100.
2.3 | Perinatal death
The risk of perinatal death (PND) at any gestational age is obtained 
by dividing the number of neonates with perinatal death (antepar‐
tum or intrapartum/neonatal death) in each stratum by the total 
number of deliveries in each birthweight category.
Risk of perinatal death at week n = PNDn/DNn*100.
2.3.1 | Composite neonatal morbidity
The denominator used for the risk of neonatal morbidity (NM) is all 
alive fetuses (AF) born at that gestation, since only alive fetuses can 
suffer morbidity.
Risk of neonatal morbidity at week n = NMn/AFn*100.
2.3.2 | Composite adverse perinatal outcome
The numerator is all neonates with perinatal death (PND) or morbid‐
ity (NM) in each stratum and the denominator all deliveries in each 
birthweight category (DN).
Risk of adverse perinatal outcome at week n = (PNDn + NMn)/
DNn*100.
A post‐hoc analysis for all separate components of morbidity was 
performed to differentiate further which outcome contributes most 
to the found difference between male and female neonates.
Data were analyzed with the SAS statistical software package 
version 9.2 (SAS Institute Inc., Cary, NC, USA).
2.4 | Ethical approval
The data in the perinatal registry are anonymous and exempt from 
ethical approval. The Netherlands Perinatal Registry gave approval 
for the use of the data for this study (approval number 13.73).
3  | RESULTS
From 1 January 1999 until 31 December 2010 a total of 2 078 327 
singleton pregnancies between 25 and 42 weeks without congenital 
anomalies were identified in the PERINED database. After exclusion 
of non‐white European women (n = 335 426 [16%]) and infants with 
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an unknown gender (n = 70 [0.004%]), our study population con‐
sisted of 1 742 831 pregnancies.
Baseline characteristics of the cohort are presented in Table 1. 
There were more male (n = 895 272 [51.4%]) than female infants 
(n = 847 559 [48.6%]) in the cohort. There were no statistically signifi‐
cant differences in maternal baseline characteristics between the two 
groups. However, women with a male fetus were more likely to have a 
hypertensive complication of pregnancy compared with women with 
a female fetus (9.3 vs 9.0%, P < 0.001). Women with a male fetus were 
more likely (all P < 0.001) than women with a female fetus to undergo 
an emergency cesarean section (8.5 vs 7.1%) or vaginal instrumental 
delivery (12.2% vs 10.0%). The rate of preterm delivery (<37 weeks of 
gestation) was higher among males than among females (6.4 vs 5.4%). 
Average birthweight in males was 124 g (95% CI 122‐126) higher than 
in females (3525 vs 3401 g; P < 0.001). Finally, male and female fe‐
tuses were equally likely to be SGA (8.9%) or LGA (11%).
Interaction between fetal sex and gestational age at delivery was 
statistically significant for antepartum death (P < 0.001), intrapar‐
tum/neonatal death (P < 0.001) and neonatal morbidity (P < 0.001). 
Interaction between fetal sex and birthweight percentile was also 
significant for all outcome measures (all P < 0.001). Therefore, out‐
comes are presented stratified for four strata of gestational age 
at delivery (25+0‐27+6 weeks, 28+0‐31+6 weeks, 32+0‐36+6 weeks, 
37+0‐42+6 weeks) and three strata of birthweight percentile (SGA, 
normal weight and LGA).
3.1 | Antepartum death
Table 2 shows the relative risk for antepartum death separately 
for four strata of gestational age at delivery (25+0‐27+6 weeks, 
28+0‐31+6 weeks, 32+0‐36+6 weeks, 36+6‐42+6 weeks) and three 
strata of birthweight percentile (SGA, normal weight and LGA).
Antepartum death occurs more often in SGA males than SGA 
females after 28+0 weeks (from 28+0 to 31+6 weeks, RR 1.40, 95% CI 
1.17‐1.67; from 32+0 to 36+6 weeks, RR 1.34, 95% CI 1.15‐1.57; from 
37+0 to 42+6 weeks, RR 1.16, 95% CI 1.02‐1.32).
For normal weight and LGA infants, there was no statistically 
significant difference between males and females. The analysis 
 
Male infants Female infants
P value(n = 895 272) (n = 847 559)
Maternal characteristics
Maternal age, years (mean), (SD) 30.7 (4.6) 30.7 (4.7) 0.24
Nulliparous, n (%) 426 995 (47.7) 403 106 (47.6) 0.08
Low socioeconomic status, n (%) 172 737 (19.3) 163 006 (19.2) 0.30
Pregnancy and delivery characteristics
Conception IVF/ICSI, n (%) 24 856 (2.8) 23 375 (2.8) 0.46
Hypertensive disordersa, n (%) 83 170 (9.3) 76 100 (9.0) <0.0001
Induction of labor, n (%) 191 330 (21.4) 182 001 (21.5) 0.10
Mode of delivery
Spontaneous vaginal delivery,  
n (%)
654 129 (73.1) 647 524 (76.4) <0.0001
Instrumental vaginal delivery,  
n (%)
109 448 (12.2) 84 552 (10.0)  
Elective cesarean, n (%) 55 269 (6.2) 55 556 (6.6)  
Emergency cesarean, n (%) 76 426 (8.5) 59 957 (7.1)  
Neonatal characteristics
Gestational age at delivery (wk), 
median (IQR)
39 (38‐40) 40 (39‐40) <0.0001
Delivery <32 wk GA, (%) 8110 (0.9) 6438 (0.8) <0.0001
Delivery <37 wk GA, (%) 57 353 (6.4) 45 980 (5.4) <0.0001
Birthweight (g), mean (SD) 3525 (597) 3401 (564) <0.0001
Birthweight <p10 (SGA) 79 442 (8.9) 75 691 (8.9)  
Birthweight p10‐p90 (normal 
weight)
719 424 (80.4) 677 826 (80.0)  
Birthweight ≥p90 (LGA) 96 406 (10.8) 94 042 (11.1)  
Abbreviation: SD, standard deviation.
aPreexisting hypertension, pregnancy‐induced hypertension, preeclampsia. 
TA B L E  1   Characteristics of the 
1 742 831 singleton white European 
pregnancies without congenital anomalies 
in the Netherlands, 1999‐2010
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for all infants (not stratified into SGA, normal weight and LGA) 
shows that antepartum death occurs more often in males than 
in females born between 32+0 and 36+6 weeks (RR 1.12, 95% CI 
1.02‐1.22).
3.2 | Intrapartum and neonatal death
Table 3 shows the rates of intrapartum/neonatal death. In most 
groups, there were no significant differences between males and 
females. However, normal weight males born between 25+0 and 
27+6 weeks GA had an increased risk of intrapartum/neonatal death 
compared with females (RR 1.20, 95% CI 1.02‐1.40).
The analysis for all infants (not stratified into SGA, normal weight 
and LGA) shows that intrapartum/neonatal death occurs more often 
in males than in females born between 37+0 and 42+6 weeks (RR 1.11, 
95% CI 1.01‐1.22).
3.3 | Perinatal death
Table 4 shows the rates of perinatal death. In most groups, there were 
no significant differences between males and females. However, SGA 
males born between 37+0 and 42+6 weeks GA had an increased risk of 
perinatal death compared with females (RR 1.06, 95% CI 1.01‐1.12).
In contrast, the analysis for all infants (not stratified into SGA, 
normal weight and LGA) shows that perinatal death occurs less often 
in males than in females born between 28+0 and 31+6 weeks (RR 0.95, 
95% CI 0.90‐0.99).
3.4 | Composite morbidity
The composite morbidity of males and females is shown in Table 5.
The risk of composite morbidity was significantly increased in 
males compared with females in most (8/12) strata, with relative risks 
ranging from 1.07 to 1.36. All males born after 32+0 weeks of gestation 
have an increased risk of neonatal morbidity compared with females.
The analysis for all infants (not stratified into SGA, normal 
weight and LGA) shows that composite morbidity was significantly 
increased in males compared with females born after 28+0 weeks, 
with relative risks ranging from 1.07 to 1.34.
3.5 | Composite adverse perinatal outcome
The composite adverse neonatal outcome of males and females is 
shown in Table 6.
The risk of composite adverse neonatal outcome was signifi‐
cantly increased in males compared with females in most (7/12) 
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight <p10 (SGA)
25‐27 wk GA 397/79 442 0.50 371/75 691 0.49 1.02 (0.89‐1.17)
28‐31 wk GA 303/78 863 0.38 206/75 223 0.27 1.40 (1.17‐1.67)
32‐36 wk GA 370/78 017 0.47 264/74 710 0.35 1.34 (1.15‐1.57)
37‐42 wk GA 503/73 106 0.69 420/70 774 0.59 1.16 (1.02‐1.32)
Birthweight p10‐p90 (normal weight)
25‐27 wk GA 277/719 424 0.04 304/677 826 0.04 0.86 (0.73‐1.01)
28‐31 wk GA 404/718 042 0.06 422/676 696 0.06 0.90 (0.79‐1.03)
32‐36 wk GA 597/713 388 0.08 563/673 002 0.08 1.00 (.89‐1.12)
37‐42 wk GA 937/671 723 0.14 978/640 051 0.15 0.91 (0.83‐1.00)
Birthweight ≥p90 (LGA)
25‐27 wk GA 31/96 406 0.03 29/94 042 0.03 1.04 (0.63‐1.73)
28‐31 wk GA 46/96 243 0.05 44/93 850 0.05 1.02 (0.67‐1.54)
32‐36 wk GA 36/95 757 0.04 24/93 409 0.03 1.46 (0.87‐2.45)
37‐42 wk GA 131/93 090 0.14 122/90 754 0.13 1.05 (0.82‐1.34)
All birthweights
25‐27 wk GA 705/895 272 0.08 704/847 559 0.08 0.95 (0.85‐1.05)
28‐31 wk GA 753/893 148 0.08 672/845 769 0.08 1.06 (0.96‐1.18)
32‐36 wk GA 1003/887 162 0.11 851/841 121 0.10 1.12 (1.02‐1.22)
37‐42 wk GA 1571/837 919 0.19 1520/801 579 0.19 0.99 (0.92‐1.06)
Abbreviations: CI, confidence interval; LGA, large‐for‐gestational age; RR, relative risk ratio; SGA, 
small‐for‐gestational age.
aRR calculated with fetus at risk approach, meaning the numerator is all neonates with antepartum 
death in each stratum and the denominator all women remaining pregnant at the beginning of the 
gestational age stratum in each birthweight category. 
TA B L E  2   Antepartum death rate 
in males and females by birthweight 
percentiles and gestational age category
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strata, with relative risks ranging from 1.04 to 1.31. All males born 
after 32+0 weeks of gestation have an increased risk of adverse neo‐
natal outcome compared with females.
The analysis for all infants (not stratified into SGA, normal 
weight and LGA) shows that composite morbidity was significantly 
increased in males compared with females born after 28+0 weeks, 
with relative risks ranging from 1.04 to 1.28.
The individual components of the composite neonatal morbid‐
ity (IRDS, sepsis, NEC, meconium aspiration, PPHN, periventric‐
ular leukomalacia, Apgar score <7 at 5 minutes and ICH) were also 
analyzed separately (Tables S1‐S8). IRDS was increased in males 
compared with females at most gestational ages, regardless of birth‐
weight percentile (Table S1). Sepsis was increased in all term males 
compared with females regardless of birthweight. Between 32+0 and 
36+6 weeks the risk of sepsis was only increased in normal weight 
males (Table S2). PPHN was only increased in normal weight males 
at term compared with females (Table S5). For periventricular leu‐
komalacia, although in only one stratum, a decreased risk was found 
for SGA males between 25+0 and 27+0 weeks of gestation (Table S6). 
The risk of ICH was increased in all normal weight males compared 
with females regardless of gestational age at delivery and in LGA 
males born between 28+0 and 31+6 weeks of gestation (RR 1.52, 
95% CI 1.08‐2.13) (Table S6). The incidence of an Apgar score <7 at 
5 minutes was increased in all term males compared with females re‐
gardless of birthweight. Furthermore, SGA males between 25+0 and 
27+0 and 32+0 and 36+6 weeks of gestation were at increased risk 
(Table S7). The incidence of NEC (Table S3) and meconium aspiration 
(Table S4) was not significantly different between males and females.
4  | DISCUSSION
In our study, we analyzed 1 742 831 singleton deliveries and as‐
sessed differences in pregnancy outcomes between males and 
females after adjustments for differences in fetal growth. SGA 
males have an increased risk of antepartum death and all males 
born after 32+0 weeks of gestation have an increased risk of neo‐
natal morbidity compared with females. Differences in neonatal 
morbidity are mainly caused by increased risks of sepsis, IRDS and 
ICH in males compared with females.
Our study has some limitations. These limitations are mainly re‐
lated to the fact that we performed a database study and conse‐
quently had to rely on information that was recorded in the registry. 
To assess differences in the incidence of adverse outcome, large 
numbers are needed. In our opinion, it would not have been feasible 
to collect enough data using a different study design.
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight <p10 (SGA)
25‐27 wk GA 61/182 34 41/97 42 0.79 (0.58‐1.08)
28‐31 wk GA 68/543 13 30/307 9.8 1.28 (0.85‐1.92)
32‐36 wk GA 110/4541 2.4 103/3672 2.8 0.86 (0.66‐1.13)
37‐42 wk GA 263/72 603 0.36 232/70 354 0.33 1.10 (0.92‐1.31)
Birthweight p10‐p90 (normal weight)
25‐27 wk GA 298/1105 27 186/826 23 1.20 (1.02‐1.40)
28‐31 wk GA 203/4250 4.8 173/3272 5.3 0.90 (0.74‐1.10)
32‐36 wk GA 303/41 068 0.73 202/323 88 0.62 1.18 (0.99‐1.41)
37‐42 wk GA 549/670 786 0.08 470/639 073 0.07 1.11 (0.98‐1.26)
Birthweight ≥p90 (LGA)
25‐27 wk GA 21/132 16 36/163 22 0.72 (0.44‐1.17)
28‐31 wk GA 33/440 7.5 31/397 7.8 0.96 (0.60‐1.54)
32‐36 wk GA 24/2631 0.91 27/2631 1.0 0.89 (0.51‐1.54)
37‐42 wk GA 64/92 959 0.07 53/90 632 0.06 1.18 (0.82‐1.69)
All birthweights
25‐27 wk GA 380/1419 27 263/1086 24 1.08 (0.94‐1.25)
28‐31 wk GA 304/5233 5.8 234/3976 5.9 0.99 (0.84‐1.16)
32‐36 wk GA 437/48 240 0.91 332/38 691 0.86 1.06 (0.92‐1.22)
37‐42 wk GA 876/836 348 0.10 755/800 059 0.09 1.11 (1.01‐1.22)
Abbreviations: CI, confidence interval; GA, gestational age; LGA, large‐for‐gestational age; RR, 
relative risk ratio; SGA, small‐for‐gestational age.
aRR calculated as: the numerator is all neonates with intrapartum or neonatal death in each stratum 
and the denominator all deliveries without antepartum death in each birthweight category. 
TA B L E  3   Intrapartum and neonatal 
death rate in males and females by 
birthweight percentiles and gestational 
age category
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Secondly, the Dutch Perinatal registry did not contain reliable 
data on the use of betamethasone, maternal smoking, diabetes or 
maternal body mass index because these data were not mandatory 
fields in the perinatal registration during the study period, and as a 
result not reliably registered. All these factors are associated with 
adverse pregnancy outcome, but it is unlikely that there is a fetal sex‐
based bias. Betamethasone administration is based on gestational 
age and is not sex‐dependent, and no publications about a relation 
between maternal smoking, diabetes or BMI and fetal sex could be 
retrieved. Adverse neonatal outcome could not be more clearly de‐
fined than that judged by the clinician within the first admission after 
birth, therefore we do not expect a fetal sex‐based bias. In addition, 
there are probably unknown factors causally related to perinatal 
outcome, such as maternal smoking and hypertensive disorders. By 
adjusting for birthweight percentile it is possible that our results are 
partly distorted by a biasing path through the unmeasured factors.21
Women with a male fetus were more likely to have a hyperten‐
sive complication of pregnancy compared with women with a female 
fetus (9.3 vs 9.0%, P < 0.001). This is in accordance with findings in 
previous research.22 The association might be term‐dependent, but 
this is outside the scope of this study.
The PERINED database does not contain quantitative data on 
the method of pregnancy dating. According to the ruling guideline 
during the study period, pregnancy dating was predominantly per‐
formed by first trimester ultrasound measurements (crown‐rump 
length). If no first trimester dating was performed, dating was based 
on head‐circumference measurement or last menstrual period. In the 
rare cases when dating was done in the second trimester, a sex‐de‐
pendent difference in estimation, since boys are already somewhat 
larger than girls on average at that time23 may disturb these analy‐
ses. Because the majority of ultrasound dating was done in the first 
trimester we do not expect a substantial influence on our results. 
Also, in case of antepartum death—especially in the preterm period—
the gestational age of delivery is not the same as the moment of fetal 
demise. Although this might cause a structural underestimation of 
birthweight percentile, it is unlikely that this time‐effect is different 
between males and females. Also, the difference between fetal de‐
mise and delivery and thus possible overestimation of SGA in case 
of antepartum death is likely small at term, because—according to 
the Dutch protocol—all pregnant women in the term period undergo 
weekly checkups including Doppler auscultation of the fetal heart 
rate.
We used population‐based birthweight percentiles.18 Individual 
growth potential and placental characteristics might have enabled 
more accurate prediction of growth restriction and adverse out‐
come.24,25 We were not able to correct for this because maternal 
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight <p10 (SGA)
25‐27 wk GA 458/579 79 412/468 88 0.77 (0.37‐0.73)
28‐31 wk GA 371/846 44 236/513 46 0.96 (0.89‐1.05)
32‐36 wk GA 480/4911 9.8 367/3936 9.3 1.02 (0.96‐1.09)
37‐42 wk GA 766/73 106 1.0 652/70 774 0.92 1.06 (1.01‐1.12)
Birthweight p10‐p90 (normal weight)
25‐27 wk GA 575/1382 42 490/1130 43 0.97 (.90‐1.04)
28‐31 wk GA 607/4654 13 595/3694 16 0.89 (0.84‐0.95)
32‐36 wk GA 900/41 665 2.2 765/32 951 2.3 0.97 (0.92‐1.01)
37‐42 wk GA 1486/671 723 0.22 1448/640 051 0.23 0.99 (0.95‐1.03)
Birthweight ≥p90 (LGA)
25‐27 wk GA 52/163 32 65/192 34 0.95 (0.73‐1.22)
28‐31 wk GA 79/486 16 75/441 17 0.97 (0.81‐1.15)
32‐36 wk GA 60/2667 2.2 51/2655 1.9 1.08 (0.89‐1.27)
37‐42 wk GA 195/93 090 0.21 175/90 754 0.19 1.04 (0.94‐1.14)
All birthweights
25‐27 wk GA 1085/2124 51 967/1790 54 0.95 (0.89‐1.01)
28‐31 wk GA 1057/5986 18 906/4648 19 0.95 (0.90‐0.99)
32‐36 wk GA 1440/49 243 2.9 1183/39 542 3.0 0.99 (0.95‐1.03)
37‐42 wk GA 2447/837 919 0.29 2275/801 579 0.28 1.01 (0.99‐1.04)
Abbreviations: CI, confidence interval; GA, gestational age; LGA, large‐for‐gestational age; RR, 
relative risk ratio; SGA, small‐for‐gestational age.
aRR calculated as: the numerator are all neonates with perinatal death (antepartum or intrapartum/
neonatal death) in each stratum and the denominator all deliveries in each birthweight category. 
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length and weight, and placental weight and pathology are not reg‐
istered in the Dutch Perinatal Registry. We do not expect a system‐
atical bias.
Furthermore, ultrasound growth charts used to detect SGA fe‐
tuses are not gender‐specific. Therefore it is possible that girls (who 
are by definition smaller than male fetuses) are more often SGA com‐
pared with boys, perhaps leading to earlier intervention (induction) 
and thereby preventing antepartum death. This possible bias cannot 
be ruled out and should be investigated in further studies.
Our data did not allow us to make statements about the influ‐
ence of mode of delivery on neonatal death and morbidity. Table 1 
shows differences in induction of labor and instrumental deliveries 
between males and females. These are often a result of suspected 
compromised fetal condition rather than a confounder of adverse 
outcome. We can only hypothesize that the higher rate of vaginal 
instrumental delivery among males might be associated with the in‐
creased risk of ICH among males; another explanation could be that 
the ICH occurred antenatally and caused fetal distress. This is not 
within the scope of this paper and should be investigated in future 
studies. Finally, there might be an association between the higher 
incidence of cesarean sections among males and the risk of IRDS, 
although information on timing of the cesarean section and adminis‐
tration of betamethasone is lacking.
Finally, some causes of neonatal morbidity are predominantly a 
problem in the extreme preterm period, whereas others occur at all 
gestational ages or mainly at term. We decided to use a composite 
outcome containing important causes of neonatal morbidity available 
in the PERINED registry to provide useful information for clinicians. 
Stratification into four categories of gestational ages at delivery en‐
sures that an automatic distinction is made between causes of mor‐
bidity that predominantly occur among extremely preterm infants 
and causes of morbidity that occur at all gestational ages. Separate 
tables for all causes of morbidity are provided as Tables S1‐S8.
The main strength of this study is the size (1 742 831 preg‐
nancies) and composition of the cohort. Data are derived from a 
large, well‐maintained population‐based national perinatal registry 
(1999‐2010). Cohorts of all previous studies were smaller (549 up 
to 469 152 pregnancies)11,25 and often included anomalous fetuses 
and/or twins. The proportion of male infants, the incidence of an‐
tepartum deaths, intrapartum/neonatal deaths and composite neo‐
natal morbidity that we found in this study are in accordance with 
previous research.7,14,26‐30
Secondly, as discussed in the introduction, previous studies 
falsely suggest a higher risk of adverse outcome among males be‐
cause the absolute number of adverse outcomes among males was 
divided by the number of adverse outcomes among females. Using 
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight <p10 (SGA)
25‐27 wk GA 94/121 78 48/56 86 0.91 (0.78‐1.05)
28‐31 wk GA 324/475 68 190/277 69 0.99 (0.90‐1.10)
32‐36 wk GA 535/4431 12 366/3569 10 1.18 (1.04‐1.33)
37‐42 wk GA 1723/72 340 2.4 1320/70 122 1.9 1.27 (1.18‐1.36)
Birthweight p10‐p90 (normal weight)
25‐27 wk GA 674/807 84 527/807 82 1.01 (0.97‐1.06)
28‐31 wk GA 2602/4047 64 1861/3099 60 1.07 (1.03‐1.11)
32‐36 wk GA 3754/40 765 9.2 2550/32 186 7.9 1.16 (1.11‐1.22)
37‐42 wk GA 9292/670 237 1.4 6533/638 603 1.0 1.36 (1.31‐1.40)
Birthweight ≥p90 (LGA)
25‐27 wk GA 87/111 78 105/127 83 0.95 (0.84‐1.08)
28‐31 wk GA 248/407 60 197/366 54 1.13 (1.00‐1.28)
32‐36 wk GA 274/2607 11 213/2604 8.2 1.28 (1.08‐1.52)
37‐42 wk GA 1698/92 895 1.8 1233/90 579 1.4 1.34 (1.25‐1.44)
All birthweights
25‐27 wk GA 855/1039 82 680/823 83 0.99 (0.95‐1.04)
28‐31 wk GA 3174/4929 64 2248/3742 60 1.07 (1.04‐1.11)
32‐36 wk GA 4563/47 803 9.5 3129/38 359 8.2 1.17 (1.12‐1.22)
37‐42 wk GA 12 713/835 472 1.5 9086/799 304 1.1 1.34 (1.30‐1.37)
Abbreviations: CI, confidence interval; GA, gestational age; LGA, large‐for‐gestational age; RR, 
relative risk ratio; SGA, small‐for‐gestational age.
aRR calculated as: the numerator is all alive neonates with morbidity in each stratum and the de‐
nominator all alive neonates in each birthweight category. 
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the fetus at risk approach avoids bias through unequal numbers of 
male and female fetuses at a certain gestational age. Also—in con‐
trast to previous studies—outcomes were stratified for birthweight 
percentile and gestational age at delivery. This enables comparison 
of male and female infants within the same birthweight percentile 
category and gestational age group, and rules out bias through the 
association between male sex and premature delivery. As a result, 
the outcomes most closely represent the influence of fetal sex on 
the outcomes of interest and allowed us to check for associations 
between fetal growth, gender and adverse outcome.
To our knowledge this is the first study that tested for interaction 
and consequently performed analyses stratified for gestational age 
at delivery and birthweight percentile.
This was a hypothesis‐generating study. Unknown or unmeasured 
factors may have caused these associations. After appropriate correc‐
tion for birthweight percentile and gestational age, the results of this 
study put previous studies in perspective that showed increased an‐
tepartum death, intrapartum/neonatal death and neonatal morbidity 
in males compared with females.10‐14 These higher adverse outcome 
rates might not be caused by actual increased chances of adverse out‐
come among males but by the increased risk of preterm delivery in 
males,3‐9 by adjustment for absolute birthweight instead of birthweight 
percentile, and calculation of male/female ratios of adverse outcome 
that was not adjusted for differences in the total number of male and 
female infants born. In contrast to previous studies, we found no in‐
creased risk of antepartum, intrapartum/neonatal and perinatal death 
in normal weight and LGA males born after 28+0 weeks. We found an in‐
creased risk of antepartum death (after 28+0 weeks) and neonatal mor‐
bidity (after 32+0 weeks) among SGA males, and only increased risk in 
perinatal death among SGA males born between 37+0 and 42+6 weeks.
This study shows increased composite morbidity and composite 
adverse perinatal outcome among all males born after 32+0 weeks of 
gestation. The higher neonatal morbidity rate in males seems to be 
mainly caused by higher rates of IRDS, sepsis and ICH in males. The 
effect of higher neonatal morbidity on long‐term health outcomes 
in males in our cohort is unsure. Previous research showed higher 
rates of bronchopulmonary dysplasia and increased mortality in very 
preterm SGA infants and very low birthweight infants.31,32
We hypothesize that genetic differences between males and 
females might underlie the fetal sex‐related differences. This study 
gives no clues on how to decrease neonatal morbidity in male infants.
The results of this study matter because they correct the erro‐
neous idea that all male infants suffer more antepartum, intrapar‐
tum/neonatal and perinatal death than female infants. The main 
 
Male infants Female infants
RRa (95% CI)(n = 895 272) % (n = 847 559) %
Birthweight <p10 (SGA)
25‐27 wk GA 552/579 95 460/468 98 0.97 (0.95‐0.99)
28‐31 wk GA 695/846 82 426/513 83 0.99 (0.94‐1.04)
32‐36 wk GA 1015/4911 21 733/3936 19 1.11 (1.02‐1.21)
37‐42 wk GA 2489/73 106 3.4 1972/70 774 2.8 1.22 (1.15‐1.30)
Birthweight p10‐p90 (normal weight)
25‐27 wk GA 1249/1382 90 1017/1130 90 1.00 (0.98‐1.03)
28‐31 wk GA 3209/4654 69 2456/3694 66 1.04 (1.01‐1.07)
32‐36 wk GA 4654/41 665 11 3315/32 951 10 1.11 (1.06‐1.16)
37‐42 wk GA 10 778/671 723 1.6 7981/640 051 1.2 1.29 (1.25‐1.32)
Birthweight ≥p90 (LGA)
25‐27 wk GA 139/163 85 170/192 89 0.96 (0.89‐1.05)
28‐31 wk GA 327/486 67 272/441 62 1.09 (0.99‐1.21)
32‐36 wk GA 334/2667 13 264/2655 10 1.26 (1.08‐1.47)
37‐42 wk GA 1893/93 090 2.0 1408/90 754 1.6 1.31 (1.22‐1.40)
All birthweights
25‐27 wk GA 1940/2124 91 1647/1790 92 0.99 (0.97‐1.01)
28‐31 wk GA 4231/5986 71 3154/4648 68 1.04 (1.02‐1.07)
32‐36 wk GA 6003/49 243 12 4312/39 542 11 1.12 (1.08‐1.16)
37‐42 wk GA 15 160/837 919 1.8 11 361/801 579 1.4 1.28 (1.25‐1.31)
Abbreviations: CI, confidence interval; GA, gestational age; LGA, large‐for‐gestational age; RR, 
relative risk ratio; SGA, small‐for‐gestational age.
aRR calculated as: the numerator are all neonates with perinatal death (antepartum or intrapartum/
neonatal death) or morbidity in each stratum and the denominator all deliveries in each birthweight 
category. 
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implication of this study is awareness of differences between male 
and female perinatal outcome. Our study has further focused on 
which domain these differences lie.
Further intervention studies should be aware of sex differences 
in perinatal outcome and should perform prespecified analyses sep‐
arately for male and female infants. The importance of this advice 
has already been shown in a recent intervention study that found 
differences in effectiveness of allopurinol between male and female 
fetuses.33 This could lead to a more tailored approach fit for the in‐
dividual neonate to improve outcomes. In addition, future research 
could be aimed at unraveling mechanisms that might play a role in 
the increased neonatal morbidity in males.
5  | CONCLUSION
SGA males have an increased risk of antepartum death and all males 
born after 32+0 weeks of gestation have an increased risk of neonatal 
morbidity compared with females. Differences in neonatal morbidity 
are mainly caused by increased risks of IRDS, sepsis, PPHN, Apgar 
score <7 at 5 minutes and ICH in males compared with females. In 
contrast to findings in previous studies, we found no increased risk 
of antepartum, intrapartum/neonatal and perinatal death in normal 
weight and LGA males born after 28+0 weeks.
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